Clinical Studies for Pep2Dia, the bioactive for blood sugar management 4 January 2022
Pep2Dia ® is a 100% natural ingredient obtained from French milk.
Pep2Dia® is made for those willing to maintain healthy blood sugar levels and improve their health.
Pep2Dia® contains an Alanine-Proline dipeptide which inhibits intestinal alpha-glucosidase enzyme responsible for converting sugars into glucose, resulting in the reduction of blood sugar.
Preclinical and clinical Pep2Dia® studies have demonstrated a significant reduction in postprandial blood sugar levels, as well as the absence of side effects and toxicity.
During this presentation Joanna Moro, Bioactives Clinical Trials Specialist at Ingredia, analyses the differents clinical studies led for Pep2Dia® and the results.
Watch the presentation now!
Contact us to learn more on our bioactive!News